| Date | Title | Description |
| 08.07.2026 | Agrifood Tech Booms: Innovation Fuels Sustainable Food Systems Amid Market Shifts | Agrifood technology surges with fresh capital. Startups secure major funding across diverse sectors. Plant-based innovation, AI in agriculture, and sustainable practices drive growth. Strategic mergers reshape the industry landscape. Regula... |
| 02.07.2026 | Omni Raises $14.6M in Series A Funding | Omni, a London, UK-based developer of vet-formulated plant-based pet food and supplements, raised $14.6m in Series A funding.
The round was co-led by IW Capital and Redrice Ventures, with participation from RootBridge Capital, Digitalis Ven... |
| 18.06.2026 | Jetstream Venture Fund Invests In Rejuvenate Bio Alongside Merck | Jetstream Venture Fund announced that it has established an investment interest in Rejuvenate Bio, a biotechnology company focused on gene therapy-based treatments for chronic and age-related diseases.
The investment gives Jetstream exposur... |
| 15.06.2026 | Rejuvenate Bio Accelerates Gene Therapy with $6M Funding, Merck Partnership | Rejuvenate Bio, a San Diego biotechnology innovator, secured $6 million in vital financing. This capital propels its pioneering gene therapy platform. The company targets age-related and chronic diseases. Focus areas include companion anima... |
| 12.06.2026 | Rejuvenate Bio Closes $6 Million Financing And Strategic R&D Collaboration With Merck Animal Health | Lifespan Vision Ventures announced that its portfolio company, Rejuvenate Bio, has completed a $6 million financing round and entered into a strategic research and development collaboration with Merck Animal Health, marking a key milestone ... |
| 11.06.2026 | Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health | Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals.
NORWALK, Conn., June 11, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm f... |
| 07.05.2026 | Travv Closes $1.6M Seed Funding Round | Travv, a Stillwater, OK-based provider of an AI-native diagnostic platform for veterinary medicine, closed a $1.6m seed funding round.
The round was led by Digitalis Ventures, with participation from AniVC.
The company intends to use the fu... |
| 28.03.2026 | Clasp: $20 Million Raised To Scale Clinician Retention Platform | Clasp, a healthcare workforce infrastructure company, announced a $20 million Series B funding round to expand its clinician retention platform and scale its ROTC-style hiring model across the U.S. healthcare system. The round was led by Cr... |
| 27.03.2026 | Clasp Raises $20M Series B Funding | Clasp, a Boston, MA-based provider of a retention-driven recruitment platform, raised $20M in Series B funding.
The round was led by Crosslink Capital and Digitalis Ventures, with participation from Juvo, Strada Education, Frank Britt, and ... |
| 11.01.2026 | EpiBiologics Secures $107M Series B, Propelling Precision Protein Degradation for Cancer and Immunity | EpiBiologics closed a $107 million Series B. This investment accelerates its EpiTAC platform. The platform develops tissue-selective extracellular protein degraders. These target disease-driving membrane and soluble proteins. Lead candidate... |
| 10.01.2026 | EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline | EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and J... |
| 08.01.2026 | EpiBiologics Closes $107M Series B Funding | EpiBiologics, a San Mateo, CA-based company which specializes in tissue-selective extracellular protein degradation, raised $107M in Series B funding.
The round was co-led by GV (Google Ventures) and Johnson & Johnson, through its corpo... |
| 01.12.2025 | Protego Biopharma: $130 Million Series B Funding Closed To Advance Pivotal AL Amyloidosis Program | Protego Biopharma has closed an oversubscribed $130 million Series B financing round that will accelerate its first-in-class AL amyloidosis therapeutic program into a pivotal clinical study. The round was led by Novartis Venture Fund and Fo... |
| 18.11.2025 | T-Therapeutics Secures $91 Million to Advance Bispecific Therapies | T-Therapeutics boosts Series A to $91M. New funds will push cancer, autoimmune bispecifics to trials. OpTiMus platform aims to unlock undruggable targets. Investors show strong confidence.
**T-Therapeutics Secures $91 Million to Advance Bis... |
| 14.11.2025 | T-Therapeutics: Series A Extended To $91 Million As It Advances First-In-Class Bispecifics Toward The Clinic | T-Therapeutics has expanded its Series A financing to a total of $91 million after securing an additional $32 million from new and existing investors. The Cambridge-based biotechnology company, which develops next-generation T cell receptor... |
| 13.11.2025 | Cambridge startup T-Therapeutics secures €27.5 million to improve how the immune system targets disease | T-Therapeutics, a British BioTech company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, today announced the successful expansion of its Series A financing, raising a further €27.5 million (... |
| 21.10.2025 | Faeth Therapeutics Secures $25M to Propel Cancer Metabolism Therapies | Faeth Therapeutics secured $25 million, raising its total capital to $92 million. This vital funding drives its lead PIKTOR program for endometrial cancer into Phase 2, following an impressive 80% response rate. It also expands the AI-drive... |
| 21.10.2025 | Faeth Therapeutics Raises $25M in Funding | Credit: Faeth Therapeutics
Faeth Therapeutics, an Austin, Texas-based clinical-stage biotechnology company advancing therapies that systematically target tumor metabolism, raised $25m in funding.
The financing, which brought total capital r... |
| 20.10.2025 | Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer | Faeth Therapeutics, a clinical-stage biotechnology company pioneering metabolism-based cancer therapies, announced a $25 million strategic financing round to advance its lead program, PIKTOR, in endometrial cancer. The raise brings Faeth’s ... |
| 06.08.2025 | Positive Development Raises $51.5M Funding | Positive Development, a Mclean, VA-based provider of developmental therapy for autistic children and their families, raised $51.5M in funding.
The round was led by aMoon and existing investors B Capital and Flare Capital Partners, and conti... |
| 25.07.2025 | ASTRA Therapeutics Secures €8.3 Million Seed Funding, Revolutionizing Animal Health Parasiticides | ASTRA Therapeutics, a Swiss biotech innovator, recently secured €8.3 million in seed funding. This significant capital influx fuels its vital mission: pioneering precision parasiticides for animal health. ASTRA's unique ParaX platform engin... |
| 25.07.2025 | Frisches Kapital für die Parasitenbekämpfung |
Das 2022 gegründete Biotech-Startup ASTRA Therapeutics entwickelt neuartige Parasitenwirkstoffe, sogenannte Parasitizide. Zur Anwendung kommen sollen die Wirkstoffe dereinst beispielsweise in der Veterinärmedizin, wo Parasiten durch Hemmun... |
| 24.07.2025 | ASTRA Therapeutics raises CHF 7.75 million in seed financing round to advance precision Parasiticides for Animal Health | ASTRA Therapeutics raises CHF 7.75 million in seed financing round to advance precision Parasiticides for Animal Health
Thu, Jul 24, 2025 10:52 CET Report this content
Round co-led by MIG Capital (CHF 3 million) and Digitalis Ventures (CHF ... |
| 24.07.2025 | Swiss BioTech platform ASTRA Therapeutics raises €8.3 million to advance precision Parasiticides for animal health | Villigen-based ASTRA Therapeutics, a BioTech startup designing drugs against eukaryotic pathogens based on its proprietary platform, announced today they have raised a Seed funding round of €8.3 million.
The round was led by VC firm MIG Cap... |
| 24.07.2025 | ASTRA Therapeutics raises CHF 7.75M to advance precision parasiticides in animal health | Founded in 2022 by Dr. Natacha Gaillard and Dr. Ashwani Sharma, ASTRA Therapeutics focuses on eukaryotic pathogens—organisms that cause illness and death in animals, humans, and crops. Existing treatments in this area are increasingly limit... |
| 08.07.2025 | Gallant Secures $18M to Transform Pet Healthcare | Gallant, an animal health biotechnology leader, secured $18 million in Series B funding. Digitalis Ventures led the round. BOLD Capital, Hill Creek Partners, and NovaQuest Capital Management also participated. This capital infusion accelera... |
| 02.07.2025 | Gallant: $18 Million Series B Raised For Ready-To-Use Stem Cell Therapies For Pets | Gallant, an animal health biotechnology company focused on developing off-the-shelf stem cell therapies for pets, announced it has closed its $18 million Series B financing. The funding round was led by Digitalis Ventures, with continued su... |
| 05.03.2025 | Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director | ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of... |
| 07.01.2025 | Jeito Capital's Bold Moves in Biopharma: A Strategic Investment Landscape | In the world of biopharma, where innovation is the lifeblood, Jeito Capital is making waves. This Paris-based private equity fund is not just dipping its toes; it’s diving deep into the ocean of clinical-stage biotech. With a recent investm... |
| 07.01.2025 | French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics | Paris-based Jeito Capital, a PE fund focused on biopharma innovation, has furthered its position as a player in global healthcare investment with two major contributions to clinical-stage biotech companies Aviceda Therapeutics and XyloCor T... |
| 07.01.2025 | Aviceda raises $207M series C to take geographic atrophy drug through phase 3 | Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 readout this year for its lead eye disease drug.
The round was co-led by the healthcare funds Omega Funds and TCGX, wi... |
| 23.10.2024 | Alpha-9 Oncology Raises $175M in Series C Financing | Alpha-9 Oncology Inc., a Boston, MA- and Vancouver, Canada-based clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, raised $175m in Series C financing.
The round was le... |
| 22.10.2024 | Terray Therapeutics: $120 Million (Series B) Secured To Improve Human Health | Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, announced Series B fu... |
| 17.10.2024 | Terray Therapeutics Closes $120M Series B Funding Round | Terray Therapeutics, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B funding.
The round was led by Bedford Ridge Capital and existing investor NVent... |
| 30.07.2024 | BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors | WESTBURY, N.Y., July 30, 2024 /PRNewswire/ -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the appointment of Dr. Judith Dunn and Dr. Auro Nair to its Board of Dir... |
| 25.07.2024 | GRO Biosciences Secures $60 Million to Revolutionize Gout Treatment**
** | ** In the bustling world of biotechnology, innovation is the lifeblood. GRO Biosciences, or GRObio, has just taken a giant leap forward. The company recently announced the closing of an oversubscribed $60.3 million Series B financing round.... |
| 19.07.2024 | GRO Biosciences: Protein Therapeutics Company Raises $60 Million In Series B | GRO Biosciences (GRObio), a biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the closing of an oversubscribed $60.3 million Series B fin... |
| 21.05.2024 | Expressable Raises $26M in Series B Funding | Expressable, an Austin, TX-based company which specializes in research-based, family-centered speech therapy care, raised $26M in Series B funding.
The round was led by HarbourVest Partners, with participation from Digitalis Ventures and ex... |
| 13.04.2023 | First Ever AI-Powered Dog Playmate, Companion, Raises Additional $6 Million from Lerer Hippeau, Digitalis Ventures and Officially Opens Reservations | Companion, the first ever AI-powered interactive device for dogs, announced that it has raised $6M in additional funding from Lerer Hippeau and Digitalis Ventures alongside opening its product to the public for reservation. The new capital ... |
| 19.10.2022 | Digitalis Ventures Closes Fourth Fund, at $300M | Digitalis Ventures, a NYC-based venture capital firm, closed of its fourth fund, totaling $300m in commitments.
The new capital will be invested in entrepreneurs and researchers developing breakthrough science and technology with the potent... |
| 07.09.2022 | Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program | Roche announced Wednesday that it is paying $250 million in cash to acquire Good Therapeutics, a Seattle-based preclinical biotech company.
Good has raised a little over $30 million since it was founded in 2016. The company is focused on cy... |
| 18.01.2022 | Faeth raises $20m from Khosla, AgFunder to battle cancer with food | Disclosure: AFN’s parent company, AgFunder, is an investor in Faeth Therapeutics.
Faeth Therapeutics, a startup developing precision nutrition solutions to help fight cancer, has raised $20 million in seed funding in a round led by Khosla V... |
| 18.01.2022 | BREAKING: Faeth raises $20m from Khosla, AgFunder to battle cancer with food | Disclosure: AFN’s parent company, AgFunder, is an investor in Faeth Therapeutics.
Faeth Therapeutics, a startup developing precision nutrition solutions to help fight cancer, has raised $20 million in seed funding in a round led by Khosla V... |
| 29.10.2021 | Meet the New BallerTV CTO Holding Court at Pickup Basketball Games as Sports Seasons Rebound | If you stop by Koreatown's Immanuel Presbyterian Church on Sundays, you might run into Kavodel Ohiomoba pushing a broom across a basketball court hidden on an upper floor of the cavernous historic French Gothic cathedral. It's a favorite mo... |
| 22.09.2021 | UnifiHealth Secures $5.4MM to Propel Availability of Modern Health Plan for Small Businesses | With this funding, we’re making good on our promise of bridging the gap between coverage that businesses can actually afford with coverage that people actually need.
COLUMBUS, Ohio (PRWEB) September 22, 2021
Today, UnifiHealth, the modern h... |
| 10.05.2021 | How Pacaso Makes It Easier for More People to Own a Second Home | Austin Allison's love of real estate surfaced at age four or five when he would work with a hammer in hand alongside his dad, who was a carpenter.
He bought his first house at age 17 and began selling real estate at 18.
Now, Allison is CEO ... |
| 26.04.2021 | How the Pandemic Has Changed Fans' Experience for Good | The COVID-19 pandemic has separated friends, family and colleagues and halted most in-person shared experiences. On the flip side, over the past year gaming, sports and entertainment companies have found new ways to help keep us engaged, co... |
| 12.09.2017 | Kenzen: Combining US sales culture with Swiss technology | |
| 07.08.2017 | Remote monitoring startup for smoking cessation raises $6M to add caregiving support | Eran Ofir, Somatix founder and CEO, said in a phone interview that Digitalis Ventures led the Series A round for the business, which opened U.S. offices in New York and has taken part in accelerators run by Dreamit Health and New York Digit... |
| 15.03.2017 | CareDox raises $6.4M Series A for student healthcare | Schools provide the front line of health for many Americans, but they're too often overlooked
Editor's note: Our Splash Health, Wellness and Wearables event is coming up on March 23 in San Francisco. We'll have Mario Schlosser (Founder &... |
| 05.01.2017 | Term Sheet — Thursday, January 5 | THE 21 BEST TECH IPOS of 2016, ETC
Visions: SoftBank has been purposely opaque about many aspects of Vision Fund, its $100 billion (!) tech investment fund, in part, because the fund isn’t closed yet and general solicitation rules prevent i... |
| 05.01.2017 | Digitalis Raises $100M Fund | Digitalis announced today the launch of a $100 million fund for seed- and early-stage companies seeking to address the most challenging problems in human health. Digitalis, with offices in New York, San Francisco and Los Angeles, was founde... |
| 04.01.2017 | Digitalis Launches $100M Venture Capital Fund Focused on Human Health | Digitalis has launched a $100m fund focused on seed- and early-stage companies seeking to address the most challenging problems in human health.
Founded in 2016 by Geoffrey W. Smith, managing partner, Digitalis invests in solutions at the i... |
| 04.01.2017 | Digitalis Ventures launches $100M healthcare innovation fund | Venture capital firm Digitalis, which was founded last year and has offices in New York and California, has launched a $100 million fund to spur innovation in healthcare by investing in early and seed stage companies that leverage math, sci... |
| 06.12.2016 | Tyson Joins List of Food Companies with Venture Capital Funds | This week, Tyson Foods joined the growing list of food companies with venture capital funds investing in food and agritech startups.
The company, which earlier this year shocked the sector by making an investment in plant-based meat alterna... |
| - | Remote monitoring startup for smoking cessation raises $6M to add caregiving support | Somatix, an Israeli digital health company using wearables to track unhealthy behaviors and send timely alerts to change the user’s behavior, has raised $6 million in a Series A round. The fundraise is intended to add new products to a pipe... |
| - | LA Venture: How WorkLife Ventures Founder Brianne Kimmel Became a Top Angel Investor | How do angel investors get in front of companies prior to investing? Brianne Kimmel, founder of WorkLife Ventures, might know a way or two.
On this episode of the LA Venture podcast, Kimmel discusses her work as an investor — how she gets i... |
| - | LA Venture: Digitalis Ventures' Drew Taylor on How Investing in Pet Health Creates Opportunities for Humans | On this week's episode of the L.A. Venture Podcast, hear from Drew Taylor, a partner at Digitalis Ventures.
The firm first launched in 2016 with a $100 million fund invested in companies that focus on improving human health. Two years later... |
